425: Strive CMO Reposts Merger Update with Semler Scientific

Strive, Inc.'s Chief Marketing Officer reposted a communication on X.com regarding the company's proposed business combination with Semler Scientific, Inc.

Summary

• Strive, Inc. filed a Form 425 communication related to its proposed business combination with Semler Scientific, Inc., which was reposted by Strive's Chief Marketing Officer, Arshia Sarkhani, on December 29, 2025.
• The communication primarily serves as a cautionary statement regarding forward-looking statements concerning the proposed transaction, including expectations about strategic and financial benefits, timing, and integration.
• It emphasizes that forward-looking statements are subject to inherent risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• The filing directs investors and stockholders to the Registration Statement on Form S-4, Information Statement/Proxy Statement/Prospectus, and other SEC filings for comprehensive details about the proposed transaction, Strive, and Semler Scientific.

Sentiment

Score: 5

Explanation: The filing is a procedural communication regarding a proposed merger, which inherently carries both potential strategic benefits and significant risks. It does not present financial results or operational updates, leading to a neutral sentiment as the outcome is uncertain and dependent on future events and successful integration.

Positives

• The proposed business combination between Strive and Semler Scientific is anticipated to yield strategic and financial benefits for the combined company, including positive impacts on future financial performance.

Negatives

• The communication highlights numerous risks and uncertainties associated with the proposed transaction, which could lead to actual results differing materially from expectations.
• Potential for the proposed transaction to not close as expected or at all due to unmet conditions.
• Anticipated benefits, including cost savings and strategic gains, may not be realized due to various factors, including changes in Bitcoin treasury strategies and risks with digital assets.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Potential for dilution caused by Strive's issuance of additional shares of Class A common stock.
• Adverse reactions from customers or changes to business/employee relationships due to the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The future outlook for the combined company following the proposed business combination includes expectations of strategic and financial benefits, successful integration of businesses, and positive impacts on future financial performance. However, these are forward-looking statements subject to significant risks and uncertainties, including those related to market conditions, regulatory changes, and the integration process itself.

Management Comments

• Arshia Sarkhani, Chief Marketing Officer of Strive, Inc., reposted the communication on X.com on December 29, 2025, in connection with the proposed business combination.

Industry Context

The proposed business combination between Strive and Semler Scientific represents a strategic move in the market, potentially aiming for synergy and expanded market presence. The explicit mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests a strategic pivot or significant involvement in the digital asset space, which is a notable trend across various industries, particularly in finance and technology, indicating a potential diversification or focus for the combined entity.

Corporate Governance

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor for the proposed transaction.

Stakeholder Impact

• Shareholders: Potential for dilution due to Strive's issuance of additional shares, and changes in share price before closing. Required to make voting decisions on the merger.
• Employees: Potential changes to employee relationships as a result of the announcement or completion of the proposed transaction.
• Customers: Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Management: Diversion of management's attention from ongoing business operations and opportunities during the integration process.

Next Steps

• Semler Scientific stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus and other relevant SEC documents before making any voting or investment decision.
• Approval of the proposed transaction by Semler Scientific stockholders.
• Closing of the proposed transaction.
• Successful integration of the combined businesses.

Key Dates

Recommendation

This filing is a procedural communication about a proposed business combination, not a financial performance update. While mergers can unlock significant value, this document primarily highlights the extensive risks and uncertainties involved, including potential integration difficulties, dilution, and the non-realization of anticipated benefits. Without detailed financial projections for the combined entity or a clearer path to synergy realization, a 'hold' recommendation is prudent. Investors should await the definitive Information Statement/Proxy Statement/Prospectus and further financial disclosures to make an informed decision, carefully weighing the potential strategic benefits against the outlined risks.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Corporate Governance, Bitcoin Treasury Strategies, Digital Assets, Proxy Solicitation